Global Artificial Implants Market By Overview
- The target market size is expected to increase at a rate of USD 144.3 Billion by 2035.
- In 2024, artificial implants market size was worth at USD 80.3 Billion.
- The market is expanding at a 6.1% CAGR.
Artificial implants are medical devices or materials that are surgically placed inside the body to replace, support a damaged or missing body part. The artificial implants market refers to the industry that involved in the development, manufacturing, and distribution of various type of medical plants.
The growing demand for facial surgery, dental & breast implants, Technological advancements in biocompatible materials, 3D printing, and minimally invasive surgical techniques & increasing prevalence of chronic disorders, projected to drive artificial implants market growth.
Impact of AI in Artificial Implants Market:
Artificial Intelligence (AI) significantly impact on artificial implants market by enhancing the design, manufacturing, and patient outcomes by advancing the manufacturing techniques. AI algorithms can analyze patient-specific data, such as medical imaging and anatomy, to design implants based on individual patient need. AI with the integration of 3D printing technology, allows for rapid production of customized implants based on AI-driven models.
Global Artificial Implants Market By Drivers & Restraints
Key Drivers of Target Market:
Increasing Demand for Cosmetic Surgery and Aesthetic Procedures Raise the Market Growth
Increasing demand for cosmetic implants, such as facial implants, breast implants, and dental implants due to the increased focus on the advancement in minimally invasive surgery. The introduction of technologically advanced products, such as nom-invasive body contouring systems, that use fat-frizzing technology, is expected to drive target market growth. Healthcare professionals and manufacturer are developing cutting edge aesthetic equipment, which rises the demand for aesthetic procedures for cosmetic surgery, is anticipated to drive artificial implants market growth.
- For instance, in January 2021, Allergen Aesthetics, launched CoolSculpting Elite, a next-generation fat reduction system which is specially designed to complement the body’s natural curves. CoolSculpting Elite is harmless technology, which target, freeze, and eliminate the targeted fat cells. It is FDA approved fat burning technology that treat fat bungles in nine areas of the body including the thigh, abdomen, flank, and others.
Restraints:
High Costs of Implants and Procedures Disrupt the Target Market Growth
Advanced materials, such as titanium or biocompatible ceramics are expensive to produce. The manufacturing process involves precise use of advanced technologies, such as 3D printing & AI-design implants can be costly. The cost of surgery is high for low-income countries patients, and integration of advanced technologies in smaller lab is difficult at the initial stage.
- Counterbalance Statements: As the manufacturing technologies advances, the cost of producing implants decreases. Advancement in 3D printing allows for customized implants and collaborated with manufacturer to reduce initial setup overall cost. Minimally invasive techniques can lower the cost of implant procedures.
Opportunities & Market Trends:
Technological Advancement in Implant Design Surge Market Growth
Technological advancements in implant design and materials creates significant opportunity for artificial implants market growth. Advanced 3D printing allows for the customized implants to provide better fit, leading to reduced complications, and enhances the comfort after surgery. The use of AI in implant design improve the precision of custom implant creation that help to create the most optimal design based on patients anatomy, ensuring a better fit and faster recovery time, resulting in artificial implants market expansion.
- For instance, in November 2020, Medtronic plc completed acquisition of Medicrea, for transformation of spinal surgery through artificial intelligence (AI), predictive modeling and patient specific implants. The Medicrea solution is a predictive modeling and cultured algorithms that measure and digitally reconstruct a patient’s spine to its optimal profile. This acquisition expands Medtronic's artificial intelligence and data capabilities, to offer an integrated spine solution including AI-driven surgical planning, personalized spinal implants and robotic assisted surgery.
Global Artificial Implants Market By Segmentations & Regional Insights
The artificial implants market is distributed into type, biomaterials, end-user, and region.
Type:
Based on type, the target market is divided into dental implants, orthopedic implants, cardiovascular implants, neurological implants, and ocular implants. The dental implants hold the largest artificial implants market share as it plays a critical role in oral health replacement. The aging populations, aesthetic consideration, and increase in number of dental issues, is projected to drive artificial implants market growth.
- For instance, in April 2024, DENTIS, a Korean provider of implant-based dental and medical solutions had launched its local subsidiary in New Delhi, India. These include the Submerged Qualified (SQ) implant lineup, advanced dental prosthesis devices, and the SQ Guide, a digital implant guide system personalized for SQ implant fixtures.
Biomaterials:
On the basis of biomaterials, the focused market is segmented into metal, polymer, ceramic and composite. The metal segment dominates in target market due to its strength, durability, biocompatibility, and corrosion resistance, making it suitable for a variety of implants. Metals, particularly titanium and titanium alloys are used in joint replacement and spinal implants. Innovations in metal alloys for the improvement in implants, leading to the growth of artificial implants market size.
- For instance, in February 2022, DeGen Medical Inc., launched Impulse AM, a 3D printer porous titanium implant for posterior interbody fusion. Impulse AM is the first 3D-printed spinal implant which was used to utilize a different type of titanium material (Puri-Ti) with an exclusive manufacturing process. This initial product release provide implants and instrumentation designed for Posterior Lumbar Interbody Fusion (PLIF) and Transformational Lumbar Interbody Fusion (TLIF) fusion procedures and it was first interbody device that printed Puri-Ti materials.
End-user:
Hospitals, dental clinics, ambulatory surgical centers, and others are the categorized by the end-user in target market. The hospital segment leads in terms of artificial implants market share due to their ability to provide comprehensive care for complex implants procedures. Hospitals are equipped with necessary infrastructure, skilled surgeons, and advanced technologies to handle complex implant surgeries, resulting to target market expansion.
Region:
Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America: North America holds the major share in artificial implants market due to advanced healthcare system, quick uptake of sensory and neurological implants. The presence of leading medical implants companies and rising prevalence of condition such as arthritis, increases the demand for artificial implants, projected to growth of artificial implants market size.
- For instance, in March 2024, an orthopaedic surgeon at UC Davis Health was the first in the U.S. to implant a new product that can help preserve knee cartilage. The surgeon used CartiHeal Agili-C Cartilage Repair Implant to help a patient’s knee pain after an injury. The CartiHeal Agili-C is an implant used to repair damages cartilage which is absorbed by the body and gives new treatment options for patients.
Europe: This region is expected to be the second-leading region in upcoming years due to the rising geriatric populations and technological advancement in implant system. The growing healthcare infrastructure, and rising demand for cosmetic surgery & aesthetic procedures, which is expected to drive market growth over the forecast period.
Artificial Implants Market Report Scope:
Attribute |
Details |
Market Size 2025 |
USD 84.3 Billion |
Projected Market Size 2035 |
USD 144.3 Billion |
CAGR Growth Rate |
6.1% (2025-2035) |
Base year for estimation |
2024 |
Forecast period |
2025 – 2035 |
Market representation |
Revenue in USD Billion & CAGR from 2025 to 2035 |
Regional scope |
North America - U.S. and Canada Europe – Germany, U.K., France, Russia, Italy, Spain, Netherlands, and Rest of Europe Asia Pacific – China, India, Japan, Australia Indonesia Malaysia, South Korea, and Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, and Rest of Latin America Middle East & Africa – GCC, Israel, South Africa, and Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segmentation:
By Type:
- Dental Implants
- Orthopaedic Implants
- Cardiovascular implants
- Neurological Implants
- Ocular Implants
By Type:
- Metal
- Polymer
- Ceramic
- Composite
By End-user:
- Hospitals and Clinics
- Dental Clinics
- Ambulatory Surgical Centers
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Artificial Implants Market By Competitive Landscape & Key Players
The key players operating in the artificial implants market include CMR Naviscan, Delphinus Medical Technologies, Inc., Dilon Technologies and others. Companies are adopting strategies, such as new product launches, partnerships, agreement, higher investments and collaboration with other organization, which is projected to drive artificial implants market growth.
List of Key Players in the Market:
- Boston Scientific Corporation
- Stryker
- Medtronic
- Smith+Nephew
- Dentsply Sirona
- CONMED Corporation
- Abbott
- NuVasive, Inc.
- Biosensors International Group, Ltd.
- Johnson & Johnson Services, Inc.
- MicroPort
- Hollister Incorporated
- Zimmer Biomet
- Taurus Healthcare Pvt Ltd.
- Straumann Group
Global Artificial Implants Market By Recent News
- designed to improve adherence for obesity and Type-2 diabetes (T2D) treatment aimed to reducing development and manufacturing costs. Rice University’s Biotech launched Pad for the commercialization of “Rx On-site Generation Using Electronics” (ROGUE), a self-contained, durable implantable device that houses cells engineered to produce T2D and obesity therapies in response to patients’ physiological needs.
- In July 2024, The Texas Heart Institute has successfully imaplants the BiVACOR Total Artificial Heart (TAH) in human. BiVACOR’s TAH is a titanium-constructed biventricular rotary blood pump with a single moving part that utilizes a magnetically levitated rotor that pumps the blood and replaces both ventricles of a failing heart.
Analyst View:
Artificial implants market is significantly growing and transform due to advancements in technology, rising healthcare needs, increased awareness about healthcare facilities and growing investment in healthcare sector. The customized & personalized implants, impacts on rising demand for cosmetic and aesthetic procedures for facial, breast & body implants, and technological integration with biomaterials, is projected artificial implants market expansion.
More Related Reports
Artificial Intelligence in Healthcare Market
Artificial Intelligence (AI) sensor Market
Artificial Intelligence in Education System Market
TMJ Implants Market
Spinal Implant Market
Global Artificial Implants Market By Company Profile
Company Name |
Boston Scientific Corporation |
Headquarter |
Marlborough, Massachusetts, U.S. |
CEO |
Michael "Mike" Mahoney |
Employee Count (2024) |
38,000 Employees |
Global Artificial Implants Market By Highlights
FAQs
Artificial implants market size was valued at USD 84.3 Billion in 2025 and is expected to reach USD 144.3 Billion by 2035 growing at a CAGR of 6.1%.
Type, biomaterials, end-user, and region are the segmentation for the target market.
North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. North America is expected to dominate the market.
The key players operating in the artificial implants market include Boston Scientific Corporation, Stryker, Medtronic, Smith+Nephew, Dentsply Sirona, CONMED Corporation, Abbott, NuVasive, Inc., Biosensors International Group, Ltd., Johnson & Johnson Services, Inc., MicroPort, Hollister Incorporated, Zimmer Biomet, Taurus Healthcare Pvt Ltd., and Straumann Group.